Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
Hydrogels are biocompatible drug delivery systems by which the physical properties can be controlled by the cross-linking density. Hydrogels were prepared by copolymerization of acrylic acid monomers in the presence of poly(ethylene glycol)(PEG) to form polyethylene diacrylate (PEDGA). Various molecular weights of PEGs were used for the synthesis of PEGDA to study the effect of molecular weight of PEG on the properties of hydrogels. These hydrogels were further characterized for free water, swelling..


Pharmaceutical Technology


22. L.M. Soderqvist et al., "Biodegradable Polymers from Renewable Sources: Rheological Characterization of Hemicellulose-based Hydrogels," Biomacromolecules 6 (2), 684–90 (2005).

23. J.S. Mackie and P. Meares, "The Diffusion of Electrolytes in a Cation-Exchange Resin Membranes 1 Theoretical," Proc. Royal Soc. London Series A, Mathematical Phsy. Sciences, 232 (1191), 498–509 (1955).

24. M.M Pradas et al., "Porous Poly(2-hydroxyethyl acrylate) Hydrogels," Polymer 42 (10), 4667–4674 (2001).

25. G.P. Misra and R.A. Siegel, "New Mode of Drug Delivery: Long Term Autonomous Rhythmic Hormone Release Across a Hydrogel Membrane," J. Controlled Release 81 (1–2), 1–6 (2002).

26. S. Pang and M.Z. Fiume, "Final Report on the Safety Assessment of Ammonium, Potassium, and Sodium Persulfate., Int J Toxicol. 20 (Suppl 3), 7–21 (2001).

27. http://www.CHEMICALLAND21.com/, accessed Mar. 12, 2007.

28. D. Bhadra et al.,"Pegnology: A Review of PEG-ylated Systems," Die Pharmazie 57 (1), 5–29 (2002).

29. A. Nathan et al., "Hydrogels Based on Water-Soluble Poly(ether urethanes) Derived from L-Lysine and Poly(ethy1ene glycol)," Macromolecules 25, 4476–4484 (1992).

30. K. Park, W.S.W. Shalaby, and H. Park, Biodegradable Hydrogels for Drug Delivery, (Technomic Publishing Company, Inc., Basel, Switzerland, 1993), pp. 1–12, 35–66.

31. M.K. Chun, C.S. Cho,and H-K Choi "Mucoadhesive Drug Carrier Based on Interpolymer Complex of Poly(vinyl pyrrolidone) and Poly(acrylic acid) Prepared by Template Polymerization," J. Controlled Release 81 (3), 327–334 (2002).

32. G. Gates et al.," 2,3-Dihydroxypropyl Methacrylate and 2-Hydroxyethyl Methacrylate Hydrogels: Gel Structure and Transport Properties," Polymer 44 (1), 215–222 (2002).

33. A.R. Gennaro, Remington's Pharmaceutical Sciences, (Mack Publishing Company, Easton, PA, 18th ed., 1990), p. 1313.

34. http:// http://www.systat.com/products/sigmaplot/. accessed Mar. 12. 2007.

35. J. Kost and R. Langer, "Properties and Applications" in Hydrogels in Medicine and Pharmacy, N.A. Peppas, Ed. (CRC Press, Inc., FL, Vol III, 1987), pp. 95–108.

36. B.D. Ratner, "Comprehensive Polymer Science." in The Synthesis, Characterization, Reactions & Applications of Polymers, S.K. Aggarwal, Ed. (Pergamon Press, Oxford, Vol 7, 1989), pp. 201–247.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here